Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12586793

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2003 Feb 15
First author
Sledge GW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2003 Feb 15;21(4):577-9. doi: 10.1200/JCO.2003.10.086.
    note
    Source null
    related pmid
    12586789
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2003 Feb 15;21(4):580-2. doi: 10.1200/JCO.2003.10.085.
    note
    Source null
    related pmid
    12586790
    relationship
    Comment in

Authors and identifiers

  1. name
    Sledge GW
    type
    Author
  2. name
    Neuberg D
    type
    Author
  3. name
    Bernardo P
    type
    Author
  4. name
    Ingle JN
    type
    Author
  5. name
    Martino S
    type
    Author
  6. name
    Rowinsky EK
    type
    Author
  7. name
    Wood WC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sledge GW
    type
    Author
  2. name
    Neuberg D
    type
    Author
  3. name
    Bernardo P
    type
    Author
  4. name
    Ingle JN
    type
    Author
  5. name
    Martino S
    type
    Author
  6. name
    Rowinsky EK
    type
    Author
  7. name
    Wood WC
    type
    Author
bibliography ids
  1. nci-bib-488f129710d3a1b961a6a62f
book metadata
content sha256
efedb5155da7211b5ff056e2050632cba017da6fcd73aa7c25711ecc34eded3d
document type
citation
dois
  1. 10.1200/JCO.2003.08.013
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12586793
immutable id
pubmed:12586793@efedb5155da7211b5ff056e2050632cba017da6fcd73aa7c25711ecc34eded3d
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
4
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
588-92
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2003 Feb 15;21(4):577-9. doi: 10.1200/JCO.2003.10.086.
    note
    Source null
    related pmid
    12586789
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2003 Feb 15;21(4):580-2. doi: 10.1200/JCO.2003.10.085.
    note
    Source null
    related pmid
    12586790
    relationship
    Comment in
outcomes validated
false
pmid
12586793
provenance
batch id
6646708a43dc2007bef0
provider
NCBI PubMed ESummary
record sha256
95d5bbb8e5b0056143f6dd34ce85dd7a442461486c0597ba2808b77869c0d053
response sha256
2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
retrieved at
2026-09-09T23:45:48.511831+00:00
publication date
display
2003 Feb 15
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12586793/
title
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

Preserved source evidence · Not medical advice